COMP <GO>
ZTS vs MRK // GROSS PROFIT MARGIN
Zoetis Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ZTS 9
— MRK 5
▲ GROSS PROFIT MARGIN LEADER: MRK
LAST: $79.72 (+1.17%) • MKT CAP: $32.56B
gross-margins
71.80%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
gross-margins
74.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 71.80% | 74.80% | -3.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.70% | 20.70% | +5.00 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | 15.3x | -5.00 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | 3.42% | +3.59 | ZTS | /fcf-yield <GO> |
| Operating Margin | 34.40% | 34.30% | +0.10 | ZTS | /operating-margins <GO> |
| Net Profit Margin | 28.20% | 28.10% | +0.10 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | 2.30% | 1.30% | +1.00 | ZTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.53 | 5.19 | -0.66 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.60% | +0.30 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.4 | 56.9 | +3.58 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.92 | +0.07 | ZTS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 18.4x | -7.10 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.56B | $361.02B | -$328.46B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTS REV | MRK REV | ZTS GROSS % | MRK GROSS % | ZTS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.47B | $65.01B | 71.8% | 74.8% | $2.28B | $12.36B |
| FY 2024 | $9.26B | $64.17B | 70.6% | 76.3% | $2.30B | $18.10B |
| FY 2023 | $8.54B | $60.12B | 44.0% | 44.0% | $1.97B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
MRK // BETA 0.92